Genetic polymorphisms of the urea transporter gene are associated with antihypertensive response to nifedipine GITS

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 29, Issue 1, 2007, Pages 3-10

  Hong, X ^a,b   Xing, H ^b   Yu, Y ^b   Wen, Y ^b   Zhang, Y ^b   Zhang, S ^a,b   Tang, G ^b   Xu, Xiping ^a,b,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antihypertensive efficacy; Nifedipine GITS; Single nucleotide polymorphism; SLC14A2 gene

Indexed keywords

ALANINE; ISOLEUCINE; NIFEDIPINE; THREONINE; VALINE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; UREA TRANSPORTER A GENE;

ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHINA; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NIFEDIPINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS;

EID: 33947354923     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2007.29.1.1063490     Document Type: Article

References (22)

1. Chobanian, A.V., Bakris, G.L., Black, H.R. et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003, 289: 2560-72.
2. Laragh, J.H., Lamport, B., Sealey, J., Alderman, M.H. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension 1988, 12: 223-6.
3. Materson, B.J., Reda, D.J., Cushman, W.C. et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993, 328: 914-21.
4. Kurland, L., Lind, L., Melhus, H. Using genotyping to predict responses to anti-hypertensive treatment. Trends Pharmacol Sci 2005, 26: 443-7.
5. Grundy, J.S., Foster, R.T. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin Pharmacokinet 1996, 30: 28-51.
6. Salazar, A., Arocha, I. Antihypertensive efficacy and tolerance of the osmotic formulation of nifedipine: Venezuelan Multiceter Study. Acta Clinica (Bayer) 1993, 4: 11-5.
7. Rodriguez-Roa, E., Octavio, A., Mayorca, E. et al. Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day. J Hum Hypertens 2002, 16(Suppl 1): S151-S155.
8. Okaniwa, T., Ishizaki, T., Iizuka, T., Yasuda, K. Effect of nifedipine on urinary concentrating ability: A placebo controlled study. J Clin Pharmacol 1989, 29: 938-45.
9. Wang, W., Kwon, T.H., Li, C. et al. Altered expression of renal aquaporins and Na(+) transporters in rats treated with L-type calcium blocker. Am J Physiol Regul Integr Comp Physiol 2001, 280: R1632-R1641.
10. Wetzels, J.F., Wiltink, P.G., Hoitsma, A.J., Huysmans, F.T., Koene, R.A. Diuretic and natriuretic effects of nifedipine in healthy persons. Br J Clin Pharmacol 1988, 25: 547-53.
11. Larochelle, P. Renal tubular effects of calcium antagonists. Kidney Int Suppl 1992, 36: S49-S53.
12. Christensen, C.K., Lederballe Pedersen, O., Mikkelsen, E. Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs. Clin Pharmacol Ther 1982, 32: 572-6.
13. van Schaik, B.A., van Nistelrooy, A.E., Geyskes, G.G. Antihypertensive and renal effects of nicardipine. Br J Clin Pharmacol 1984, 18: 57-63.
14. Leroy, C., Basset, G., Gruel, G., Ripoche, P., Trinh-Trang-Tan, M.M., Rousselet, G. Hyperosmotic NaCl and urea synergistically regulate the expression of the UT-A2 urea transporter in vitro and in vivo. Biochem Biophys Res Commun 2000, 271: 368-73.
15. Terris, J.M., Knepper, M.A., Wade, J.B. UT-A3: Localization and characterization of an additional urea transporter isoform in the IMCD. Am J Physiol Renal Physiol 2001, 280: F325-F332.
16. Fenton, R.A., Cooper, G.J., Morris, I.D., Smith, C.P. Coordinated expression of UT-A and UT-B urea transporters in rat testis. Am J Physiol Cell Physiol 2002, 282: C1492-C1501.
17. Waller, D.G., Renwick, A.G., Gruchy, B.S., George, C.F. The first pass metabolism of nifedipine in man. Br J Clin Pharmacol 1984, 18: 951-4.
18. Ranade, K., Wu, K.D., Hwu, C.M. et al. Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Hum Mol Genet 2001, 10: 2157-64.
19. Xu, X., Rogus, J.J., Terwedow, H.A. et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet 1999, 64: 1694-701.
20. Gu, D., Su, S., Ge, D. et al. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006, 47: 1147-54.
21. Tomaszewski, M., Brain, N.J., Charchar, F.J. et al. Essential hypertension and beta2-adrenergic receptor gene: Linkage and association analysis. Hypertension 2002, 40: 286-91.
22. Weinshilboum, R. Inheritance and drug response. N Engl J Med 2003, 348: 529-37.